MIRA INFORM
REPORT
|
Report Date : |
23.02.2011 |
IDENTIFICATION DETAILS
|
Correct Name : |
IMRES B.V. |
|
|
|
|
Registered Office : |
Larserpoortweg 26, 8218NK
Lelystad |
|
|
|
|
Country : |
Netherlands |
|
|
|
|
Financials (as on) : |
31.12.2009 |
|
|
|
|
Date of Incorporation : |
28.05.1991 |
|
|
|
|
Com. Reg. No.: |
08023514 |
|
|
|
|
Legal Form : |
Limited Company |
|
|
|
|
Line of Business : |
The Import and Export of Medical and
Pharmaceutical Products. |
RATING & COMMENTS
|
MIRA’s Rating : |
A |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
Maximum Credit Limit : |
€ 250.000 |
|
Status : |
Good |
|
Payment
Behaviour : |
Regular |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30, 2010
|
Country Name |
Previous Rating (01.04.2010) |
Current Rating (30.06.2010) |
|
Netherlands |
A1 |
A1 |
|
Risk Category |
ECGC Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
CONTACT INFORMATION
|
Company name |
Imres B.V. |
|
Tradename |
Imres B.V. |
|
Address |
Larserpoortweg 26 |
|
|
8218NK Lelystad |
|
|
|
|
Mail address |
Postbus 214 |
|
|
8200AE Lelystad |
|
|
|
|
Telephone number |
0320296969 |
|
Telefax number |
0320296929 |
|
E-mail address |
|
|
Website |
CREDIT LIMIT
Credit limit A credit of €
250.000 may be granted
COMPANY INFORMATION
|
Handel Register Number 08023514 |
08023514 |
|
Registered in |
Chamber of commerce Gooi-, Eem-
en Flevoland |
|
First registration |
05-06-1991 |
|
Act of foundation |
28-05-1991 |
|
Date of constitution |
01-01-1991 |
|
Continuation date |
28-05-1991 |
|
Legal form |
Besloten Vennootschap (Limited Company) |
|
Place of constitution |
Wezep |
|
Capital |
EUR 90.756,04 |
|
Issued capital |
EUR 18.151,21 |
|
Paid up capital |
EUR 18.151,21 |
NACE-code Wholesale of pharmaceutical
goods (51461)
SBI-code Wholesale of
pharmaceutical goods (46461)
Formal objective De
import en export van medische- en farmaceutische artikelen, een en ander in de
ruimste zin (The import and export
of medical and pharmaceutical products, and one in the broadest
sense)
.
|
Employees |
Total: 39 |
|
|
|
|
Bookyear |
|
2011 |
2009 |
2008 |
|
Number |
|
39 |
39 |
39 |
|
Change |
|
0,00% |
0,00% |
0,00% |
COMPANY STRUCTURE
Shareholder Nash II B.V.
Larserpoortweg 26
8218NK LELYSTAD
KvK: 32164883
Active since: 30-12-2009
Percentage: 100.00%
Ultimate parent company Sti.
Administratiekantoor Imre
KvK: 51623021.
Holding company Nash II B.V
Larserpoortweg 26
8218NK LELYSTAD
KvK: 32164883
Subsidiary Iris Medical B.V.
Larserpoortweg 26
8218N. LELYSTAD
KVK 39092699
Affiliated companies Shelter B.V.
Larserpoortweg 26
8218N. LELYSTAD
KVK 08061835
Almires B.V.
Larserpoortweg 26
8218N.
LELYSTAD
KVK 08087258
Medivital B.V.
Larserpoortweg 26
8218N. LELYSTAD
KVK39091461
Bankers
Bankers BNP Paribas SA
ING Bankers NV
MANAGEMENT
Management
G. Schutte
Geert
Authorization: Limited authorization
Position: Manager
Date appointed: 15-06-2010
Date of birth: 16-02-1968
N.F. Zee Nico Frederic
Authorization: Fully
authorized Position: Manager
Date appointed: 28-05-1991
Date of birth: 17-02-1955
G.J. van den Bosch
Gerina Janine
Authorization: Limited authorization
Position: Proxy
Date appointed: 17-06-1996
Date of birth: 07-05-1971
H.J. Mijnheer-v Heiden
Hendrika Jacoba
Authorization: Limited authorization
Position: Proxy
Date appointed: 01-11-2004
Date of birth: 18-01-1972
J.S. Kleijburg Jannetje Suzanna
Authorization: Limited authorization
Position:
Proxy
Date appointed: 02-10-2008
Date of birth: 20-02-1963
PAYMENT INFORMATION
Payment experiences Payments are regular, no complaints are
known
Payments Based on multiple payment
experiences up to € 25.000
Quarter: 2 2010: 38 Average days
Quarter: 3 2010: 68 Average days
Quarter: 4 2010: 53 Average days
Quarter: 1 2011: 44 Average days
|
|
invoices |
current quarter |
2010 Q4 |
2010 Q3 |
2010 Q2 |
|
|
Total |
112 |
100% |
41.421 |
40.965 |
39.283 |
41.085 |
|
Within terms |
71 |
67,6% |
28.009 |
18.947 |
27.185 |
33.363 |
|
Delayed 0 - 30 |
36 |
32,4% |
13.412 |
21.540 |
8.535 |
7.722 |
|
Delayed 31 - 60 |
1 |
0,0% |
|
478 |
|
|
|
Delayed 61 - 90 |
|
|||||
|
Delayed 91 - 120 |
2 |
0,0% |
|
|
1.425 |
|
|
Delayed 120+ days |
2 |
0,0% |
|
2.138 |
|
|
FINANCIAL INFORMATION
Publication financial
statement Annual accounts 2009 are published on 16-09-2010
Annual accounts 2008 are published on 30-11 -2009
Annual accounts 2007 are published on 20-10-2008
Type of publication Consolidated
Annual account Van Imres B.V.
Larserpoortweg 26
8218N. Lelystad
Publication
KvK: 08023514
Publication according to obligations by law
CORE FIGURES
|
BOOKYEAR |
2009 |
2008 |
2007 |
|
Quick ratio |
1,12 |
1,17 |
0,77 |
|
Current ratio |
1,55 |
1,93 |
1,59 |
|
Nett workingcapital / Balance |
0,34 |
0,45 |
0,35 |
|
total |
|
|
|
|
Capital and reserves / Balance |
0,38 |
0,37 |
0,41 |
|
total |
|
|
|
|
Capital and reserves / Fixed |
8,58 |
5,45 |
7,39 |
|
assets |
|
|
|
|
Solvency |
0,61 |
0,76 |
0,69 |
|
Nett workingcapital |
3.967.000 |
4.410.000 |
3.063.000 |
|
Capital and reserves |
4.401.000 |
3.605.000 |
3.542.000 |
|
Change capital and reserves |
22,08% |
1,78% |
0,51% |
|
change short term liabilities |
51,82% |
-8,18% |
105,24% |
|
Operating profit |
3.912.000 |
3.089.000 |
2.017.000 |
|
Profitability |
positive |
positive |
positive |
Annual accounts The company is obligated to publish
its annual accounts
Last annual accounts 2009
Tendency Upward
Tendency capital and reserves
|
6M |
|
||||||||
|
4M |
|
|
|
||||||
|
zn |
|
|
|
|
|
|
|
|
|
|
0 |
|
|
i |
|
i |
|
i |
|
i |
|
2006 |
2007 |
2008 |
2009 |
||||||
Capital and reserves 2009 4.401.000
Total debt 2009 7.283.000
Current ratio 2009
1,55
Quick ratio 2009 1,12
Nett working capital 2009 3.967.000
Profitability Positive
Solvency Positive
Liquidity Sufficient
|
BOOKYEAR |
2009 |
2008 |
2007 |
|
End of bookyear |
31-12-2009 |
31-12-2008 |
31-12-2007 |
|
Intangible assets |
|
37.000 |
38.000 |
|
Tangible assets |
406.000 |
517.000 |
339.000 |
|
Financial assets |
107.000 |
107.000 |
102.000 |
|
Fixed assets |
513.000 |
661.000 |
479.000 |
|
Stocks and work in progress |
3.129.00 |
3.593.000 |
4.265.000 |
|
Accounts receivable |
7.804.000 |
5.532.000 |
3.920.000 |
|
Liquid assets |
238.000 |
30.000 |
46.000 |
|
Current assets |
11.171.000 |
9.155.000 |
8.231.000 |
|
Total assets |
11.684.000 |
9.817.000 |
8.710.000 |
|
Capital and reserves |
4.401.000 |
3.605.000 |
3.542.000 |
|
Provisions |
79.000 |
42.000 |
|
|
Trade debts suppliers |
|
1.229.000 |
|
|
Other short term debts |
|
3.515.000 |
5.168.000 |
|
Total short term debt |
7.204.000 |
4.745.000 |
5.168.000 |
|
Other liabilities |
|
1.425.000 |
|
|
Total debt |
7.283.000 |
6.212.000 |
5.168.000 |
|
Total Liabilities |
11.684.000 |
9.817.000 |
8.710.000 |
|
|
|||
|
PROFIT & LOSS ACCOUNT |
|
|
|
|
BOOKYEAR |
2009 |
2008 |
2007 |
|
Gross profit |
6.965.000 |
6.535.000 |
4.745.000 |
|
Wages employees |
1.803.000 |
1.724.000 |
1.656.000 |
|
Depreciation and amortization |
79.000 |
100.000 |
70.000 |
|
Other operating charges |
1.171.000 |
1.622.000 |
1.003.000 |
|
Operating charges |
3.053.000 |
3.446.000 |
2.729.000 |
|
Operating profit |
3.912.000 |
3.089.000 |
2.017.000 |
|
Financial income |
|
10.000 |
61.000 |
|
Financial charges |
|
287.000 |
185.000 |
|
Financial result |
-183.000 |
-277.000 |
-124.000 |
|
Result participations |
|
|
-52.000 |
|
Result before taxes |
3.729.000 |
2.812.000 |
1.841.000 |
|
Income taxes |
932.000 |
717.000 |
479.000 |
|
Result after taxes |
2.797.000 |
2.095.000 |
1.362.000 |
|
Result participations after
taxes |
-1.000 |
-32.000 |
|
|
Nett result |
2.796.000 |
2.063.000 |
1.362.000 |
COMPANY STRUCTURE
Sti. Administratiekantoor Imre (51623021)
Nash II B.V. (32164883) LELYSTAD Subsidiary
Imres B.V. (08023514) Lelystad
Subsidiary (100%)
Iris Medical B.V. (39092699) LELYSTAD
Management relation (100%)
Shelter B.V. (08061835) LELYSTAD
Subsidiary
Almires B.V. (08087258) LELYSTAD Subsidiary (100%)
Medivital B.V. (39091461) LELYSTAD
Subsidiary (100%)
B & D Health Company B.V. (32121903) HUIZEN
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.45.20 |
|
|
1 |
Rs.73.07 |
|
Euro |
1 |
Rs.61.41 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Company |
---- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this report.
The assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any risk
and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its
officials.